ALZpath

Neurology & CNS Therapeutics

Overview

Early answers. Better outcomes. Discover how ALZpath is changing Alzheimer’s diagnosis through scalable blood testing.

Key facts

These are the key facts about ALZpath on Alion as of Nov 13, 2026. ALZpath is headquartered in Carlsbad, United States. It was founded in 2020. The latest round is Venture - Series Unknown of $8.4M, announced in 2026.

Headquarters
Carlsbad, United StatesAlion company profile, updated Nov 8, 2026
Founded
2020Alion company profile, updated Nov 8, 2026
Employees
10+Alion company profile, an estimated range
Total raised
$8.4MSum of 1 equity round Alion knows
Latest round
Venture - Series Unknown · $8.4M · Jul 14, 2026SEC Form D filing · sec.gov
Official records

Funding and backers

Total raised
$8.4M
1 round on record
Latest round
$8.4M
Venture round · Jul 2026 · 4 mo ago
Team
11-50
employees, estimated range
The money's age
Fresh money
4 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 14 Raised a round Venture round $8.4M · SEC Form D 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2026 $8.4M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity ALZpath, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Michael BanvilleExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
General Catalyst
backs Truvian
Mayfield
backs Applied Cognition
Elevate Ventures
backs Monument Biosciences
GreatPoint Ventures
backs Truvian
Open Space Capital
backs Neuroglee
Charlottesville Angel Network
backs Actuated Medical
Similar startupsby what they do, their industry and backers
Monument BiosciencesVenture round $5.8M · 3 yr ago · Founded 2018 · 11-50 employees
Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias.
MODAGSeries A $14M · 7 yr ago
Weltweit sind ca. 10 Millionen Menschen von Parkinson betroffen. Parkinson ist nach der Alzheimer-Krankheit die häufigste neurodegenerative…
Actuated Medical11-50 employees
Precision Brain Access for Deep Brain Therapies Millions of patients with Parkinson's disease, Alzheimer's disease, brain cancer, epilepsy…
Applied Cognition
Applied Cognition is a platform therapeutic company developing drugs to enhance brain glymphatic function and treat Alzheimer’s disease.
Glassskullneuro
A first-in-class neurotherapeutic discovery platform that decodes blood to reveal the biology of the living brain, and targets the causes…
Biophysical TherapeuticsConvertible Note $35k · 3 yr ago · Founded 2022
Biophysical Therapeutics is a biotechnology pharmaceutical drug longevity start-up company that uses computational biology. Developing…

Financials

Total raised
$8.4M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $8.4M Details

People

Michael Banville
Executive Officer
SEC Form D
Jerre Stead
Director
SEC Form D
Harry Johns
Director
SEC Form D
John Courtney
Director
SEC Form D
John Hensing
Director
SEC Form D
Irit Rappley
Director
SEC Form D
Samantha Haeberlein
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Carlsbad United States
HQ
10-50 est. staff

How to cite this page

Alion, "ALZpath: key facts", as of Nov 13, 2026. https://alion.io/company/alzpath

These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0